Diagnosis and management of eosinophilic asthma: a US perspective.
about
Group 2 innate lymphoid cells: new players in human allergic diseasesPeriostin: its role in asthma and its potential as a diagnostic or therapeutic targetInsights into Group 2 Innate Lymphoid Cells in Human Airway DiseaseHouse Dust Endotoxin Levels Are Associated with Adult Asthma in a U.S. Farming Population.Baicalein, wogonin, and Scutellaria baicalensis ethanol extract alleviate ovalbumin-induced allergic airway inflammation and mast cell-mediated anaphylactic shock by regulation of Th1/Th2 imbalance and histamine release.At the bench: understanding group 2 innate lymphoid cells in disease.Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study.Effect of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol on Immune Functions in Healthy Adults in a Randomized Controlled Trial.Humoral immune factors and asthma among American Indian children: a case-control study.Mepolizumab.Targeting Interleukin-5 in Patients With Severe Eosinophilic Asthma: A Clinical Review.Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects.Reduced clot retraction rate and altered platelet energy production in patients with asthma.The Role of Periostin in the Occurrence and Progression of Eosinophilic Chronic Sinusitis with Nasal Polyps.Reslizumab (Cinqair): An Interleukin-5 Antagonist for Severe Asthma of the Eosinophilic Phenotype.Epigenome-wide association study of asthma and wheeze in childhood and adolescence.Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric Oxide.Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets.Role of innate lymphoid cells in obesity and metabolic disease (Review).MUC18 regulates IL-13-mediated airway inflammatory response.Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use
P2860
Q27021604-EA764670-66BC-45C4-A687-4AD67FA30DB2Q27021972-4A4014A6-6064-4D62-9766-B5E538E5BA00Q28076134-CDA7BB98-39DE-462B-9AEF-B216C346AC5BQ29048404-B427A06C-B82F-4C06-BF10-86C072878387Q33903353-F911A90D-22A1-4353-B78D-8225E83FEE41Q35115465-D77AAE0F-D157-473A-A619-F4F18595B76CQ35772670-46C6A009-73C4-41A1-9355-DBF89884304DQ35802602-386102FC-0129-4AFE-8D08-44DE3E8179CAQ36050653-DD5809CF-CAD6-45DA-BBC4-463E4FCE175BQ36977252-511F8941-1C36-4F5B-B975-5BDC2532B384Q37645627-B67146D7-A611-4CD5-8166-A77A5722E4C0Q38661881-D93155D7-6B58-4AE1-88AD-1EC4FA767E4FQ39795377-7D5BC297-9446-4FC8-8361-C19415850C65Q41529243-751AD1E7-D5FE-4BCF-A0C2-669D758B955CQ41655611-F1CED4B2-8395-4F5A-850D-02A648EBE2E9Q42377365-13AE1B85-6BE3-472E-AFF7-20C58445C86AQ47790691-68D19D38-E896-420C-A709-97854CEA14AEQ48681818-27464141-8972-4548-8147-28F972283331Q49187045-60E7D075-87E5-4A77-9A2D-DBC962BA754FQ51030656-A14C6BDB-27E6-4492-AD83-29F6529070F4Q58698606-62AD11E7-CA38-4AE0-8171-8C170F014791
P2860
Diagnosis and management of eosinophilic asthma: a US perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnosis and management of eosinophilic asthma: a US perspective.
@en
Diagnosis and management of eosinophilic asthma: a US perspective.
@nl
type
label
Diagnosis and management of eosinophilic asthma: a US perspective.
@en
Diagnosis and management of eosinophilic asthma: a US perspective.
@nl
prefLabel
Diagnosis and management of eosinophilic asthma: a US perspective.
@en
Diagnosis and management of eosinophilic asthma: a US perspective.
@nl
P2860
P356
P1476
Diagnosis and management of eosinophilic asthma: a US perspective.
@en
P2093
Hannah H Walford
P2860
P356
10.2147/JAA.S39119
P407
P577
2014-04-11T00:00:00Z